期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Objective Type 2 diabetes mellitus (T2DM) is often accompanied by undiagnosed dyslipidemia. Research on the association of unconventional lipid marker......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background Waist circumference (WC), visceral adiposity index (VAI), lipid accumulation product (LAP), and Chinese visceral adiposity index (CVAI) are......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background Evidence regarding thyroid-stimulating hormone (TSH) levels within the normal range and mortality in adults with diabetes is scarce. This s......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background The triglyceride-glucose (TyG) index is a new alternative measure for insulin resistance. This meta-analysis was conducted to assess the as......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background: Whether smoking modifies the associations of diabetes and risk factor management with subsequent risk of cardiovascular disease (CVD), and......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background The triglyceride-glucose index (TyG index) has emerged as a reliable surrogate marker of insulin resistance associated with arterial stiffn......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background This study aimed to investigate the associations between the triglyceride-glucose (TyG) index in young adulthood with incident cardiovascul......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background and aims The effect of dapagliflozin (DAPA) on the prognosis of patients with acute myocardial infarction (AMI) is unclear. The present stu......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background Previous studies reported that there was right ventricular (RV) systolic dysfunction in patients with hypertension. The aim of this study w......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Objective: To evaluate the impact of stress hyperglycemia on the in-hospital prognosis in non-surgical patients with heart failure and type 2 diabetes......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background Cardiometabolic multimorbidity (CMM) is becoming increasingly common in patients with hypertension, and it is well established that healthy......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background The triglyceride-glucose (TyG) index is known as a reliable alternative marker of insulin resistance (IR), which has been regarded as a pre......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background Recent literature reported the biological role of C-peptide, but this role is still controversial and unclear. The primary aim of this stud......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background Circulating fibrinogen-to-albumin ratio (FAR) has been proposed as a novel inflammatory biomarker and a cardiovascular disease risk predict......
期刊： CARDIOVASCULAR DIABETOLOGY, 2022; 21 (1)
Background: Recent studies have established that monocyte-derived inflammation plays a central role in the pathogenesis of type 2 diabetes mellitus (T......
